Carrie A. Thompson

Event-Free Survival at 24 Months Is a Robust End Point for Disease-Related Outcome in Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy

Matthew J. Maurer, Hervé Ghesquières, Jean‐Philippe Jais et al. · Journal of Clinical Oncology · 2014 · 410 citations · Full text

Medicine, Hematology, Oncology +17

Lenalidomide Combined With R-CHOP Overcomes Negative Prognostic Impact of Non–Germinal Center B-Cell Phenotype in Newly Diagnosed Diffuse Large B-Cell Lymphoma: A Phase II Study

Grzegorz S. Nowakowski, Betsy LaPlant, William R. Macon et al. · Journal of Clinical Oncology · 2014 · 364 citations · Full text

Medicine, Hematology, Oncology +16

Rates and Outcomes of Follicular Lymphoma Transformation in the Immunochemotherapy Era: A Report From the University of Iowa/Mayo Clinic Specialized Program of Research Excellence Molecular Epidemiology Resource

Brian K. Link, Matthew J. Maurer, Grzegorz S. Nowakowski et al. · Journal of Clinical Oncology · 2013 · 332 citations · Full text

Medicine, Hematology, Oncology +14

Cause of Death in Follicular Lymphoma in the First Decade of the Rituximab Era: A Pooled Analysis of French and US Cohorts

Clémentine Sarkozy, Matthew J. Maurer, Brian K. Link et al. · Journal of Clinical Oncology · 2018 · 239 citations

Medicine, Oncology, Cancer Epidemiology +12

Early event status informs subsequent outcome in newly diagnosed follicular lymphoma

Matthew J. Maurer, Emmanuel Bachy, Hervé Ghesquières et al. · American Journal of Hematology · 2016 · 225 citations · Full text

Medicine, Biostatistics, Oncology +14